Clinical Trial Update: A Randomized,Double-blind, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of MT2004 Capsule in DILI Subjects [Phase 2]

View source ↗

Summary

A Phase 2 randomized, double-blind, placebo-controlled multicenter study evaluating MT2004 Capsule for safety and efficacy in drug-induced liver injury, includi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholestatic Liver Injury
• Drug-induced Liver Injury
• Mixed Liver Injury

Drugs mentioned

• MT2004 Capsule

Snippet

Sponsor: Xi'An Aolitai Pharmaceutical Technology Co Ltd | Conditions: Drug-Induced Liver Injury, Cholestatic Liver Injury | Phase 2 | Status: UNKNOWN